Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea
· Delayed Price · Currency is KRW 7,660.00
-10.00 (-0.13%)
Apr 29, 2026, 2:38 PM KST
Vaxcell-Bio Therapeutics Revenue
In the year 2024, Vaxcell-Bio Therapeutics had annual revenue of 1.90B KRW with 13,737.28% growth. Vaxcell-Bio Therapeutics had revenue of 921.53M in the quarter ending December 31, 2024, with 6,615.06% growth.
Revenue
1.90B
Revenue Growth
+13,737.28%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
178.38B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MedPacto | 3.90B |
| ENCell | 5.26B |
| Macrogen | 195.27B |
| Amicogen | 41.98B |
| Genexine | 5.81B |
| EASY BIO,Inc. | 476.94B |
| JETEMA, | 76.90B |
| iNtRON Biotechnology | 5.74B |